These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

198 related articles for article (PubMed ID: 28025106)

  • 1. Effect of lysosomotropic molecules on cellular homeostasis.
    Kuzu OF; Toprak M; Noory MA; Robertson GP
    Pharmacol Res; 2017 Mar; 117():177-184. PubMed ID: 28025106
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Modulating cancer cell survival by targeting intracellular cholesterol transport.
    Kuzu OF; Gowda R; Noory MA; Robertson GP
    Br J Cancer; 2017 Aug; 117(4):513-524. PubMed ID: 28697173
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Leelamine mediates cancer cell death through inhibition of intracellular cholesterol transport.
    Kuzu OF; Gowda R; Sharma A; Robertson GP
    Mol Cancer Ther; 2014 Jul; 13(7):1690-703. PubMed ID: 24688051
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Lysosomotropic Drugs: Pharmacological Tools to Study Lysosomal Function.
    Pisonero-Vaquero S; Medina DL
    Curr Drug Metab; 2017; 18(12):1147-1158. PubMed ID: 28952432
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A high content screening assay for identifying lysosomotropic compounds.
    Nadanaciva S; Lu S; Gebhard DF; Jessen BA; Pennie WD; Will Y
    Toxicol In Vitro; 2011 Apr; 25(3):715-23. PubMed ID: 21184822
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Lysosomal adaptation: How cells respond to lysosomotropic compounds.
    Lu S; Sung T; Lin N; Abraham RT; Jessen BA
    PLoS One; 2017; 12(3):e0173771. PubMed ID: 28301521
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Improving the efficacy of hormone therapy in breast cancer: The role of cholesterol metabolism in SERM-mediated autophagy, cell differentiation and death.
    Leignadier J; Dalenc F; Poirot M; Silvente-Poirot S
    Biochem Pharmacol; 2017 Nov; 144():18-28. PubMed ID: 28642035
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The tumor-suppressor cholesterol metabolite, dendrogenin A, is a new class of LXR modulator activating lethal autophagy in cancers.
    Poirot M; Silvente-Poirot S
    Biochem Pharmacol; 2018 Jul; 153():75-81. PubMed ID: 29409832
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Identifying the structure-activity relationship of leelamine necessary for inhibiting intracellular cholesterol transport.
    Gowda R; Inamdar GS; Kuzu O; Dinavahi SS; Krzeminski J; Battu MB; Voleti SR; Amin S; Robertson GP
    Oncotarget; 2017 Apr; 8(17):28260-28277. PubMed ID: 28423677
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [The biological activity of lysosomotropic agents].
    Obłąk E; Krasowska A
    Postepy Hig Med Dosw (Online); 2010 Oct; 64():459-65. PubMed ID: 20966503
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Statin-mediated inhibition of cholesterol synthesis induces cytoprotective autophagy in human leukemic cells.
    Vilimanovich U; Bosnjak M; Bogdanovic A; Markovic I; Isakovic A; Kravic-Stevovic T; Mircic A; Trajkovic V; Bumbasirevic V
    Eur J Pharmacol; 2015 Oct; 765():415-28. PubMed ID: 26358205
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cross-talk between liver and intestine in control of cholesterol and energy homeostasis.
    Groen AK; Bloks VW; Verkade H; Kuipers F
    Mol Aspects Med; 2014 Jun; 37():77-88. PubMed ID: 24560594
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A review of drug-induced lysosomal disorders of the liver in man and laboratory animals.
    Schneider P; Korolenko TA; Busch U
    Microsc Res Tech; 1997 Feb; 36(4):253-75. PubMed ID: 9140926
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Lysosomotropic agents: impact on lysosomal membrane permeabilization and cell death.
    Villamil Giraldo AM; Appelqvist H; Ederth T; Öllinger K
    Biochem Soc Trans; 2014 Oct; 42(5):1460-4. PubMed ID: 25233432
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Lysosomal membrane stability plays a major role in the cytotoxic activity of the anti-proliferative agent, di-2-pyridylketone 4,4-dimethyl-3-thiosemicarbazone (Dp44mT).
    Gutierrez EM; Seebacher NA; Arzuman L; Kovacevic Z; Lane DJ; Richardson V; Merlot AM; Lok H; Kalinowski DS; Sahni S; Jansson PJ; Richardson DR
    Biochim Biophys Acta; 2016 Jul; 1863(7 Pt A):1665-81. PubMed ID: 27102538
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Time-Resolved Luminescent High-Throughput Screening Platform for Lysosomotropic Compounds in Living Cells.
    Wu KJ; Wu C; Chen F; Cheng SS; Ma DL; Leung CH
    ACS Sens; 2021 Jan; 6(1):166-174. PubMed ID: 33356166
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Concomitant intake of alcohol may increase the absorption of poorly soluble drugs.
    Fagerberg JH; Sjögren E; Bergström CAS
    Eur J Pharm Sci; 2015 Jan; 67():12-20. PubMed ID: 25444841
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Nimesulide binding site in the B0AT1 (SLC6A19) amino acid transporter. Mechanism of inhibition revealed by proteoliposome transport assay and molecular modelling.
    Pochini L; Seidita A; Sensi C; Scalise M; Eberini I; Indiveri C
    Biochem Pharmacol; 2014 Jun; 89(3):422-30. PubMed ID: 24704252
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A Comparative Study on the Alterations of Endocytic Pathways in Multiple Lysosomal Storage Disorders.
    Rappaport J; Manthe RL; Solomon M; Garnacho C; Muro S
    Mol Pharm; 2016 Feb; 13(2):357-368. PubMed ID: 26702793
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cytoplasmic vacuolization during exposure to drugs and other substances.
    Aki T; Nara A; Uemura K
    Cell Biol Toxicol; 2012 Jun; 28(3):125-31. PubMed ID: 22431173
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.